Drug Shortage Report for ENGERIX-B

Last updated on 2018-11-30 History
Report ID 49681
Drug Identification Number 02296454
Brand name ENGERIX-B (PEDIATRIC DOSE)
Common or Proper name Hepatitis B vaccine (recombinant)
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR
Packaging size 1's
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-05-16
Estimated end date Unknown
Actual end date 2018-11-29
Shortage status Resolved
Updated date 2018-11-30
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2018-11-30 French Compare
v15 2018-11-30 English Compare
v14 2018-11-27 French Compare
v13 2018-11-27 English Compare
v12 2018-09-19 French Compare
v11 2018-09-19 English Compare
v10 2018-07-25 French Compare
v9 2018-07-25 English Compare
v8 2018-07-13 French Compare
v7 2018-07-13 English Compare
v6 2018-06-13 French Compare
v5 2018-06-13 English Compare
v4 2018-05-25 French Compare
v3 2018-05-25 English Compare
v2 2018-05-17 French Compare
v1 2018-05-17 English Compare